Abstract
We describe a unique form of ocular disease called “exuberant pigmented conjunctivitis” and demonstrate the allergic response to environmental particles combined with high altitude, dust, concentrated ultraviolet rays, and extreme dryness. A nonsteroid treatment with mitomycin-C was studied to avoid known topical steroid side effects.
Similar content being viewed by others
References
Valencia M. Conjunctivits proliferante pigmentada. Hospital Metodista. Trabajo de ingreso a la Sociedad Boliviana de Oftalmología. 1989.
Aracena T. Conjunctivitis exuberante pigmentada. Palestra Panamericana Oftalmologica 1977;1:1–20.
Parra P, Pagano PB, Tessori S. Conjunctivitis exuberante pigmentada en Prurigo Solar. Rev Argent Dermatol. 1982;62:249–252.
Valda Rodríguez L, Aracena T, Sangueza P. Actinoreticulosis y conjunctivitis exuberante pigmetaria. Reporte de un caso. Med-Cutan-Ibero-Lat-Am. 1985;13:511–516.
Martinez EC. Incidencia de queratoconjunctivitis exuberante pigmentada en la cirdad de Potosi. Revista: Centro de Investigación Oftalmologica 1993;1:34–35.
Murillo G. Niveles de Inmunoglobulia E. en lagrimas de pacientes con conjunctivitis exuberante pigmetada. Trabajo de ingreso a la Sociedad Boliviana de Oftalmología. 1985.
Frucht-Perry J, Roxenman Y. The use of low-dose Mitomycin-C for prevention of recurrent pterygium. Ophthalmology 1994;101:759–762.
Rossental G, Shokanm A, Lifshitzz T, et al. The use of mitomycin in pterygium surgery. Ann Ophthalmol. 1993;25:427–428.
Karamursel E, Hilkmet H, Ge W, et al. A randomized trial of low-dose, topical Mitomycin-C in the treatment of severe vernal keratoconjunctivitis. Ophthalmology 2000;107:263–269.
Dunn JP, Seamone CD, Ostler HB, et al. Development of scleral ulceration and calcification after pterygium excision and mitomycin therapy. Am J Ophthalmol. 1991;112:343–344.
Abiose A, Merz M. Cryosurgery in the management of vernal keratoconjunctivitis. Ann Ophthalmol. 1983;15:744–747.
Author information
Authors and Affiliations
Additional information
The authors have stated that they does not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The authors also do not discuss the use of off-label products, which include unlabeled, unapproved, or investigative products or devices.
Rights and permissions
About this article
Cite this article
de Barragan, V.G., Murillo, G., de Alarcón, P. et al. Exuberant pigmented conjunctivitis epidemiology, immunology, histopathology, and treatment with mitomycin-C. Ann Ophthalmol 37, 99–104 (2005). https://doi.org/10.1385/AO:37:2:099
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/AO:37:2:099